Work

Access to and Delivery of High-Quality Cancer Care

Year: 2025

Type: article

Abstract: Cost of cancer care will exceed $245 billion by 2030 in the United States.1 The aging population faces a greater risk of cancer, and these patients increasingly access the privatized Medicare Advantage (MA) program vs the government-sponsored traditional Medicare (TM) program.1 Maganty et al2 examined the Medicare Provider Analysis and Review data (2016-2022) for 10 oncologic resections (including those for common cancers: colon, bladder, kidney, prostate, pancreas). They found that MA beneficiaries were less likely to undergo resection at high-quality hospitals, raising concern that MA may limit access to the optimal cancer surgery.

Source: JAMA Surgery

DOI: 10.1001/jamasurg.2025.4319

Authors: Norman J. Galbraith, Y. Nancy You, J. Joshua Smith

Institutions: Glasgow Royal Infirmary, University of Glasgow, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Healthcare Policy and Management

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute